简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2021-11-11 14:30 Rory McIlroy, Daniel Ricciardo, Connor McDavid, Klay Thompson, Jayson Tatum and More Join Naomi Osaka, Erling Haaland and Virat Kohli as Hyperice Athlete-Investors to Fuel Global Growth
2021-11-09 17:46 Masimo Root® with a Multimodal Brain Monitoring Algorithm May Improve Postoperative Neurocognition in Elderly Patients
2021-11-09 16:45 Yokogawa Acquires Insilico Biotechnology, Developer of Innovative Bioprocess Digital Twin Technology
2021-11-09 16:13 IntelliCentrics and EUCARE Announce Strategic Partnership Supporting Delivery of Taiwan’s High-Quality, Integrated Medical Services to the World
2021-11-09 09:11 Philip Morris International Announces Stamford Central Business District as Location of New Corporate Headquarters
2021-11-08 10:02 ENYO Pharma Announces Two Vonafexor Data Presentations at AASLD The Liver Meeting
2021-11-08 09:21 Empagliflozin shows consistent cardio-renal benefits in adults with heart failure with left ventricular ejection fraction over 40 percent regardless of chronic kidney disease status
2021-11-05 22:26 The Estée Lauder Companies Releases Fiscal 2021 Social Impact and Sustainability Report
2021-11-05 15:22 Consensus Cloud Solutions to Host Investor Call on November 9, 2021
2021-11-04 20:52 Registration Opens for SPIE Photonics West 2022
2021-11-04 18:45 Rhizen Pharmaceuticals AG Announces First Patient Dosing in a Phase I/Ib Study of Its Novel PARP Inhibitor (RP12146) in Patients With Advanced Solid Tumors
2021-11-04 18:41 Rapid Medical to Initiate the First-Ever Trial to Expand Stroke Treatment to Distal Regions of the Brain–Offering Thrombectomy Treatment to New Patient Population
2021-11-04 14:25 PierianDx Closes up to $47.5 Million of Growth Capital
2021-11-03 18:52 Sumitomo Heavy Industries Succeeds in Developing a Superconducting Cyclotron for Proton Therapy
2021-11-03 16:42 Personalis Announces Updates to NeXT Platform™ Incorporating Additional Key Profiling Capabilities for Advancing Oncology Biomarkers
2021-11-03 15:17 Nathan Jones, CEO of Xlear, Inc. Statement in Response to a Lawsuit Filed by the Department of Justice, on Behalf of the United States, Alleging That Certain Statements Made by Xlear Violated the FTC Act and the Consumer Protection Act
2021-11-03 13:28 ReValve Solutions, Inc. Announces Successful First Human Use of the Transeptal Mitral Valve Replacement
2021-11-03 11:27 Takeda Applied for Selection of “Prime Market”, Filed Corporate Governance Report With Tokyo Stock Exchange (TSE) in Line With Revised Corporate Governance Code and Published Corporate Governance Related Documents on its Website
2021-11-03 10:47 Philip Morris International Applauds U.K. Government’s Approach to Achieve its Smoke-Free Ambition
2021-11-03 10:00 ZAP Surgical Appoints Industry Veterans to Lead Chinese Market Expansion